Leukocyte immunoglobulin-like receptor subfamily B member 1 expression defines CD8+ T cell exhaustion in acute myeloid leukemia
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Yuran Miao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province 510630, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, CD8-Positive T-Lymphocytes, Leukocyte Immunoglobulin-like Receptor B1, Gene Expression Regulation, Leukemic. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is characterized by profound immune dysregulation, yet the mechanisms underlying impaired cytotoxicity remain unclear. By analyzing samples from 20 AML patients and 20 healthy donors, we integrated scRNA-seq (GSE223844), bulk transcriptomes (GSE37642, GSE71014), and TCGA-AML. Single-cell profiling, BayesPrism deconvolution, WGCNA, and multiple machine-learning algorithms were used to define immune alterations and construct a prognostic model, with peripheral blood validation through RT-qPCR and multicolor flow cytometry. We identified 11 immune and progenitor populations showing AML-specific shifts, including depletion of T/NK cells and expansion of stem-like compartments. Regulatory network and ligand–receptor analyses revealed broad immune suppression and disrupted cellular communication. Deconvolution showed extensive transcriptional remodeling of CD8+ T cells, and WGCNA identified a CD8+ T-cell gene module. Nine candidate genes were incorporated into 18 machine-learning models, with ridge regression generating a stable nine-gene prognostic signature. Enrichment analyses indicated activation of TGF-β, TNF receptor, and TCR pathways in high-risk patients. LILRB1 emerged as a central immunosuppressive hub in CD8+ T and NK cells, and experimental validation confirmed its elevated expression alongside impaired cytotoxicity in AML-derived lymphocytes. Overall, LILRB1 serves as a key immune checkpoint driving cytotoxic dysfunction, marking exhausted CD8+ T cells and CD16+ NK cells. The nine-gene signature links CD8+ T-cell impairment to poor prognosis, while NK-cell involvement positions LILRB1 as a promising therapeutic target for restoring anti-leukemic immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province 510630, China.
- National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, Chi…
ORCID-Profile: Jiaxiong Tan
Förderung
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Miao, Y., Lin, L., Chen, Z., Pan, Y., Luo, Z., & Tan, J. (2026). Leukocyte immunoglobulin-like receptor subfamily B member 1 expression defines CD8+ T cell exhaustion in acute myeloid leukemia. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag016
Vancouver
Miao Y, Lin L, Chen Z, Pan Y, Luo Z, Tan J. Leukocyte immunoglobulin-like receptor subfamily B member 1 expression defines CD8+ T cell exhaustion in acute myeloid leukemia. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag016
BibTeX
@article{Miao2026,
author = {Miao, Yuran and Lin, Liwan and Chen, Zhixi and Pan, Yun and Luo, Zhixin and Tan, Jiaxiong},
title = {Leukocyte immunoglobulin-like receptor subfamily B member 1 expression defines CD8+ T cell exhaustion in acute myeloid leukemia},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag016}
}
EUVIMED